Back to User profile » Dr Ming-Cheng Chan
Papers published by Dr Ming-Cheng Chan:
The Association Between Absolute Lymphocyte Count and Long-Term Mortality in Critically Ill Medical Patients: Propensity Score-Based Analyses
Hsiao YC, Shen PY, Wong LT, Chan MC, Chao WC
International Journal of General Medicine 2023, 16:3665-3675
Published Date: 22 August 2023
Comparing Clinical Outcomes of Tiotropium/Olodaterol, Umeclidinium/Vilanterol, and Indacaterol/Glycopyrronium Fixed-Dose Combination Therapy in Patients with Chronic Obstructive Pulmonary Disease in Taiwan: A Multicenter Cohort Study
Hsieh MJ, Chen NH, Cheng SL, Tao CW, Wei YF, Wu YK, Chan MC, Liu SF, Hsu WH, Yang TM, Lin MS, Liu CL, Kuo PH, Tsai YH
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:967-976
Published Date: 27 April 2022
Cost-effectiveness analysis of a fixed-dose combination of indacaterol and glycopyrronium as maintenance treatment for COPD
Chan M, Tan ECH, Yang MC
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1079-1088
Published Date: 4 April 2018
Hyperlipidemia in COPD is associated with decreased incidence of pneumonia and mortality: a nationwide health insurance data-based retrospective cohort study
Chan MC, Lin CH, Kou YR
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:1053-1059
Published Date: 18 May 2016
Predictive factors warrant screening for obstructive sleep apnea in COPD: a Taiwan National Survey
Hang LW, Hsu JY, Chang CJ, Wang HC, Cheng SL, Lin CH, Chan MC, Wang CC, Perng DW, Yu CJ
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:665-673
Published Date: 30 March 2016
COPD in Taiwan: a National Epidemiology Survey
Cheng SL, Chan MC, Wang CC, Lin CH, Wang HC, Hsu JY, Hang LW, Chang CJ, Perng DW, Yu CJ
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2459-2467
Published Date: 11 November 2015